|
Nagase & Co., Ltd. (8012.T) Évaluation DCF
JP | Basic Materials | Chemicals | JPX
|
- ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
- ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
- ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
- ✓ Aucune Expertise N'Est Requise; Facile À Suivre
Nagase & Co., Ltd. (8012.T) Bundle
Évaluer les perspectives financières de Nagase & Co., Ltd. Comme un expert! Cette calculatrice (8012T) DCF est équipée de données financières pré-remplies et offre une flexibilité complète pour modifier la croissance des revenus, le WACC, les marges et d'autres hypothèses cruciales pour s'aligner sur vos projections.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 799,559.0 | 830,240.0 | 780,557.0 | 912,896.0 | 900,149.0 | 930,329.1 | 961,521.1 | 993,759.0 | 1,027,077.6 | 1,061,513.4 |
| Revenue Growth, % | 0 | 3.84 | -5.98 | 16.95 | -1.4 | 3.35 | 3.35 | 3.35 | 3.35 | 3.35 |
| EBITDA | 31,294.0 | 35,269.0 | 48,958.0 | 48,294.0 | 53,033.0 | 47,662.5 | 49,260.5 | 50,912.1 | 52,619.1 | 54,383.3 |
| EBITDA, % | 3.91 | 4.25 | 6.27 | 5.29 | 5.89 | 5.12 | 5.12 | 5.12 | 5.12 | 5.12 |
| Depreciation | 12,126.0 | 13,352.0 | 13,694.0 | 14,922.0 | 16,625.0 | 15,556.4 | 16,077.9 | 16,617.0 | 17,174.1 | 17,749.9 |
| Depreciation, % | 1.52 | 1.61 | 1.75 | 1.63 | 1.85 | 1.67 | 1.67 | 1.67 | 1.67 | 1.67 |
| EBIT | 19,168.0 | 21,917.0 | 35,264.0 | 33,372.0 | 36,408.0 | 32,106.1 | 33,182.6 | 34,295.1 | 35,444.9 | 36,633.3 |
| EBIT, % | 2.4 | 2.64 | 4.52 | 3.66 | 4.04 | 3.45 | 3.45 | 3.45 | 3.45 | 3.45 |
| Total Cash | 51,408.0 | 49,254.0 | 54,211.0 | 40,897.0 | 59,410.0 | 56,540.1 | 58,435.8 | 60,395.0 | 62,419.9 | 64,512.7 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 220,384.0 | 241,995.0 | 288,614.0 | 301,084.0 | 320,186.0 | 301,868.9 | 311,990.0 | 322,450.4 | 333,261.4 | 344,435.0 |
| Account Receivables, % | 27.56 | 29.15 | 36.98 | 32.98 | 35.57 | 32.45 | 32.45 | 32.45 | 32.45 | 32.45 |
| Inventories | 95,685.0 | 97,241.0 | 157,524.0 | 169,720.0 | 147,990.0 | 146,792.1 | 151,713.8 | 156,800.4 | 162,057.6 | 167,491.1 |
| Inventories, % | 11.97 | 11.71 | 20.18 | 18.59 | 16.44 | 15.78 | 15.78 | 15.78 | 15.78 | 15.78 |
| Accounts Payable | 108,285.0 | 119,941.0 | 149,036.0 | 140,438.0 | 156,352.0 | 148,548.5 | 153,529.0 | 158,676.6 | 163,996.6 | 169,495.1 |
| Accounts Payable, % | 13.54 | 14.45 | 19.09 | 15.38 | 17.37 | 15.97 | 15.97 | 15.97 | 15.97 | 15.97 |
| Capital Expenditure | -12,373.0 | -9,568.0 | -10,454.0 | -16,917.0 | -17,754.0 | -14,633.5 | -15,124.1 | -15,631.2 | -16,155.3 | -16,696.9 |
| Capital Expenditure, % | -1.55 | -1.15 | -1.34 | -1.85 | -1.97 | -1.57 | -1.57 | -1.57 | -1.57 | -1.57 |
| Tax Rate, % | 31.42 | 31.42 | 31.42 | 31.42 | 31.42 | 31.42 | 31.42 | 31.42 | 31.42 | 31.42 |
| EBITAT | 11,995.0 | 14,098.0 | 23,123.9 | 23,792.5 | 24,969.0 | 21,341.1 | 22,056.6 | 22,796.1 | 23,560.4 | 24,350.4 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -196,036.0 | 6,371.0 | -51,443.1 | -11,466.5 | 42,382.0 | 33,975.4 | 12,948.3 | 13,382.4 | 13,831.1 | 14,294.9 |
| WACC, % | 4.56 | 4.58 | 4.6 | 4.68 | 4.64 | 4.61 | 4.61 | 4.61 | 4.61 | 4.61 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 78,958.8 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 14,581 | |||||||||
| Terminal Value | 558,430 | |||||||||
| Present Terminal Value | 445,740 | |||||||||
| Enterprise Value | 524,699 | |||||||||
| Net Debt | 105,292 | |||||||||
| Equity Value | 419,407 | |||||||||
| Diluted Shares Outstanding, MM | 115 | |||||||||
| Equity Value Per Share | 3,649.81 |
What You Will Receive
- Genuine Nagase Data: Preloaded financial metrics – from revenue to EBIT – based on real and projected figures.
- Comprehensive Customization: Modify all essential parameters (yellow cells) such as WACC, growth %, and tax rates.
- Instant Valuation Adjustments: Automatic recalculations to evaluate the influence of changes on Nagase & Co., Ltd.'s fair value.
- Flexible Excel Template: Designed for quick modifications, scenario analysis, and in-depth projections.
- Efficient and Precise: Eliminate the need to build models from the ground up while ensuring accuracy and adaptability.
Key Features
- Comprehensive DCF Calculator: Offers detailed unlevered and levered DCF valuation models tailored for Nagase & Co., Ltd. (8012T).
- WACC Calculator: Equipped with a pre-built Weighted Average Cost of Capital sheet featuring customizable inputs.
- Customizable Forecast Assumptions: Adjust growth rates, capital expenditures, and discount rates to suit your analysis.
- Integrated Financial Ratios: Examine profitability, leverage, and efficiency ratios specific to Nagase & Co., Ltd. (8012T).
- Interactive Dashboard and Charts: Visual presentations summarize essential valuation metrics for straightforward analysis.
How It Works
- Step 1: Download the Excel file for Nagase & Co., Ltd. (8012T).
- Step 2: Examine the pre-filled financial data and forecasts for Nagase & Co., Ltd. (8012T).
- Step 3: Adjust key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
- Step 4: Observe the DCF model automatically update as you modify your assumptions.
- Step 5: Evaluate the outputs and leverage the results for your investment strategies.
Why Opt for Nagase & Co., Ltd. (8012T) Calculator?
- Save Time: Get started immediately with our pre-built DCF model – no setup required.
- Enhance Accuracy: Access dependable financial data and formulas to minimize valuation errors.
- Fully Customizable: Adjust the model to align with your unique assumptions and forecasts.
- User-Friendly: Intuitive charts and outputs simplify the analysis of results.
- Endorsed by Professionals: Crafted for those who prioritize both precision and ease of use.
Who Can Benefit from This Product?
- Finance Students: Master valuation methods and practice with authentic data related to Nagase & Co., Ltd. (8012T).
- Academics: Integrate industry-standard models into your studies or research projects.
- Investors: Validate your investment theories and evaluate the valuation metrics for Nagase & Co., Ltd. (8012T).
- Analysts: Enhance your analysis process with a customizable DCF model designed for efficiency.
- Small Business Owners: Discover how major public organizations like Nagase & Co., Ltd. (8012T) are appraised and valued.
What the Template Includes
- Operating and Balance Sheet Data: Pre-filled historical data and forecasts for Nagase & Co., Ltd. (8012T), encompassing metrics such as revenue, EBITDA, EBIT, and capital expenditures.
- WACC Calculation: A dedicated worksheet for calculating the Weighted Average Cost of Capital (WACC), featuring key parameters like Beta, risk-free rate, and share price.
- DCF Valuation (Unlevered and Levered): Customizable Discounted Cash Flow models that detail intrinsic value along with comprehensive calculations.
- Financial Statements: Pre-loaded annual and quarterly financial statements to facilitate thorough analysis.
- Key Ratios: A compilation of profitability, leverage, and efficiency ratios specific to Nagase & Co., Ltd. (8012T).
- Dashboard and Charts: A visual overview of valuation outcomes and assumptions for straightforward result analysis.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.